SIGKNOW BIOMEDICAL CO., LTD.
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
Unlock our primary solution for your heart – EZYPRO® Continuous ECG Monitor,
and colorectal condition screening at home – JustWipe® FOBT Kit.
We work and care for health professionals' workflow, and strive to satisfy the clinical need, enhance the testin
and colorectal condition screening at home – JustWipe® FOBT Kit.
We work and care for health professionals' workflow, and strive to satisfy the clinical need, enhance the testin
Founded Year
2014
Unified Business No.
54621478
Status
Active
Number of Employees
0
Total Paid-in
Capital
100,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Established in 2014, we are committed to improving the diagnostic experience of patients and healthcare professionals around the globe with innovative Digital Health ready solutions that enable precise diagnosis, early detection, and prevention.
Tomorrow is now — embodied with medical grade wearables, big data, AI-enabled algorithm, our 14-day continuous patch ECG technology, and Professional-reviewed ECG reports are supporting Cardiologists and Neurologists in Asia, and shifting the Arrhythmia Diagnosis paradigm in the Region
Tomorrow is now — embodied with medical grade wearables, big data, AI-enabled algorithm, our 14-day continuous patch ECG technology, and Professional-reviewed ECG reports are supporting Cardiologists and Neurologists in Asia, and shifting the Arrhythmia Diagnosis paradigm in the Region
